Ding XC - Search Results

1

The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia.

Ding XC, Wang LL, Zhang XD, Xu JL, Li PF, Liang H, Zhang XB, Xie L, Zhou ZH, Yang J, Weichselbaum RR, Yu JM, Hu M. Ding XC, et al. J Hematol Oncol. 2021 Jun 12;14(1):92. doi: 10.1186/s13045-021-01102-5. J Hematol Oncol. 2021. PMID: 34118979 Free PMC article.

2

Consolidative thoracic radiotherapy for extensive stage small cell lung cancer.

Zhang X, Yu J, Zhu H, Meng X, Li M, Jiang L, Ding X, Sun X. Zhang X, et al. Oncotarget. 2017 Mar 28;8(13):22251-22261. doi: 10.18632/oncotarget.14759. Oncotarget. 2017. PMID: 28118612 Free PMC article. Review.

3

Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST): A case report.

Ding X, Wang L, Liu X, Sun X, Yu J, Meng X. Ding X, et al. Medicine (Baltimore). 2017 Mar;96(10):e6221. doi: 10.1097/MD.0000000000006221. Medicine (Baltimore). 2017. PMID: 28272214 Free PMC article.

4

Plasma levels of soluble programmed death ligand 1 (sPD-L1) in WHO II/III nasopharyngeal carcinoma (NPC): A preliminary study.

Yang J, Hu M, Bai X, Ding X, Xie L, Ma J, Fan B, Yu J. Yang J, et al. Medicine (Baltimore). 2019 Sep;98(39):e17231. doi: 10.1097/MD.0000000000017231. Medicine (Baltimore). 2019. PMID: 31574833 Free PMC article.

5

Ten-Year Outcomes Of Intensity-Modulated Radiotherapy (IMRT) Combine With Chemotherapy Versus IMRT Alone For Stage II Nasopharyngeal Carcinoma In The Real-World Study (RWD).

Ding XC, Fan PP, Xie P, Fan BJ, Yang J, Jiang LY, Bai XB, Yu JM, Hu M. Ding XC, et al. Cancer Manag Res. 2019 Oct 10;11:8893-8903. doi: 10.2147/CMAR.S218842. eCollection 2019. Cancer Manag Res. 2019. PMID: 31632149 Free PMC article.

6

In vitro and in vivo evaluation of the safety and efficacy of a novel liquid fiducial marker for image-guided radiotherapy.

Sun LC, Su Y, Ding XC, Xu DS, Li CM, Wang L, Li WL, Sun XD, Yu JM, Meng X. Sun LC, et al. Among authors: ding xc. Oncol Lett. 2020 Jul;20(1):569-580. doi: 10.3892/ol.2020.11591. Epub 2020 May 6. Oncol Lett. 2020. PMID: 32565982 Free PMC article.

7

The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes.

Ding XC, Wang LL, Zhu YF, Li YD, Nie SL, Yang J, Liang H, Weichselbaum RR, Yu JM, Hu M. Ding XC, et al. Front Immunol. 2020 Oct 30;11:580335. doi: 10.3389/fimmu.2020.580335. eCollection 2020. Front Immunol. 2020. PMID: 33224142 Free PMC article.

8

PD-L1 in Combination with CD8⁺TIL and HIF-1α are Promising Prognosis Predictors of Head and Neck Squamous Cell Carcinoma.

Zhou Z, Mu D, Zhang D, Zhang X, Ding X, Yang J, Bai X, Hu M. Zhou Z, et al. Cancer Manag Res. 2020 Dec 23;12:13233-13239. doi: 10.2147/CMAR.S285691. eCollection 2020. Cancer Manag Res. 2020. PMID: 33380831 Free PMC article.

9

Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade.

Si W, Liang H, Bugno J, Xu Q, Ding X, Yang K, Fu Y, Weichselbaum RR, Zhao X, Wang L. Si W, et al. Gut. 2022 Mar;71(3):521-533. doi: 10.1136/gutjnl-2020-323426. Epub 2021 Mar 8. Gut. 2022. PMID: 33685966 Free PMC article.

10

Determining optimal clinical target volume margins in high-grade glioma based on microscopic tumor extension and magnetic resonance imaging.

Nie S, Zhu Y, Yang J, Xin T, Xue S, Zhang X, Sun J, Mu D, Gao Y, Chen Z, Ding X, Yu J, Hu M. Nie S, et al. Radiat Oncol. 2021 Jun 7;16(1):97. doi: 10.1186/s13014-021-01819-0. Radiat Oncol. 2021. PMID: 34098965 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters